XALUDICIN Trademark

Trademark Overview

On Tuesday, July 8, 2014, a trademark application was filed for XALUDICIN with the United States Patent and Trademark Office. The USPTO has given the XALUDICIN trademark a serial number of 86330460. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, July 23, 2024. This trademark is owned by InQpharm Europe Limited. The XALUDICIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, for treatment of immune system support, cardiovascular system support, cholesterol control, blood pressure control, anti-infective, anti-inflammatory, joint health, energy boosting, blood sugar control and cancer treatment; Plant extracts for dietetic, nutraceutical or pharmaceutical use for the treatment of immune system support, cardiovascular system support, cholesterol control, blood pressure control, anti-infective, anti-inflammatory, joint health, energy boosting, blood sugar control and cancer treatment; health and medical food supplements derived from plants for the treatment of immune system support, cardiovascular system support, cholesterol control, blood pressure control, anti-infective, anti-inflammatory, joint health, energy boosting, blood sugar control and cancer treatment; [ food for babies; ] dietary supplements for humans and animals; [ plasters for medical purposes; ] all the aforesaid excluding goods for the treatment of acute lymphobla...
xaludicin

General Information

Serial Number86330460
Word MarkXALUDICIN
Filing DateTuesday, July 8, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, July 23, 2024
Registration Number5372391
Registration DateTuesday, January 9, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, for treatment of immune system support, cardiovascular system support, cholesterol control, blood pressure control, anti-infective, anti-inflammatory, joint health, energy boosting, blood sugar control and cancer treatment; Plant extracts for dietetic, nutraceutical or pharmaceutical use for the treatment of immune system support, cardiovascular system support, cholesterol control, blood pressure control, anti-infective, anti-inflammatory, joint health, energy boosting, blood sugar control and cancer treatment; health and medical food supplements derived from plants for the treatment of immune system support, cardiovascular system support, cholesterol control, blood pressure control, anti-infective, anti-inflammatory, joint health, energy boosting, blood sugar control and cancer treatment; [ food for babies; ] dietary supplements for humans and animals; [ plasters for medical purposes; ] all the aforesaid excluding goods for the treatment of acute lymphoblastic leukemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 11, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInQpharm Europe Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHitchin, Hertfordshire SG40TY
GB
Party NameInQpharm Europe Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHitchin, Hertfordshire SG40TY
GB
Party NameInQpharm Europe Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHitchin, Hertforshire
GB

Trademark Events

Event DateEvent Description
Friday, July 11, 2014NEW APPLICATION ENTERED
Friday, July 11, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 20, 2014ASSIGNED TO EXAMINER
Wednesday, August 20, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 10, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 30, 2014PUBLISHED FOR OPPOSITION
Tuesday, September 30, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 25, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 22, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, April 22, 2015SOU EXTENSION 1 FILED
Wednesday, May 20, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 20, 2015SOU EXTENSION 1 GRANTED
Thursday, May 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 17, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 17, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, December 9, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 18, 2016SOU EXTENSION 3 GRANTED
Tuesday, November 17, 2015SOU EXTENSION 2 FILED
Wednesday, December 9, 2015SOU EXTENSION 2 GRANTED
Thursday, December 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 16, 2016SOU TEAS EXTENSION RECEIVED
Monday, May 16, 2016SOU EXTENSION 3 FILED
Thursday, May 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 27, 2016SOU TEAS EXTENSION RECEIVED
Thursday, October 27, 2016SOU EXTENSION 4 FILED
Thursday, June 8, 2017SOU EXTENSION 5 GRANTED
Monday, November 28, 2016SOU EXTENSION 4 GRANTED
Tuesday, November 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 22, 2017SOU TEAS EXTENSION RECEIVED
Monday, May 22, 2017SOU EXTENSION 5 FILED
Wednesday, June 7, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 24, 2017NOTICE OF ALLOWANCE CANCELLED
Monday, September 11, 2017PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, September 21, 20171(B) BASIS DELETED; NEW BASIS REQUESTED
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 24, 2017TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, September 7, 2017ASSIGNED TO PETITION STAFF
Thursday, September 21, 2017EXAMINERS AMENDMENT MAILED
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2018REGISTERED-PRINCIPAL REGISTER
Monday, January 9, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 23, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 23, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 23, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, January 9, 2024TEAS SECTION 8 & 15 RECEIVED

Related Keywords

xaludicin control treatment support system blood anti health energy joint boosting